Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enovis Corp (ENOV)
Track today's live Enovis (ENOV) share price, performance and key data on this page with our current NYSE:ENOV stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Enovis share price on the NYSE exchange. Use the dropdown to switch exchange for the ENOV share price, head to our technical summary section, which provides analysis on Enovis share price buy/sell indicators using real-time data (or discuss the Enovis (ENOV) stock price today with other investors in the Enovis NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE:ENOV share price (ISIN: US1940145022) to enhance your trading decisions with our free investment tools and resources.
What Is the Enovis Corp Share Price Today?
The Enovis share price today is 29.15.
What Is the Stock Symbol for Enovis Corp
The stock symbol (or 'ticker') for Enovis Corp is "ENOV."
What Stock Exchange Does Enovis Corp Trade On?
Enovis Corp is listed and trades on the NYSE stock exchange.
Is Enovis Corp a Good Stock to Buy?
Determining whether Enovis (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NYSE:ENOV share price (ISIN: US1940145022) to enhance your trading decisions with our free investment tools and resources.
What Is the Enovis Corp Share Price Today?
The Enovis share price today is 29.15.
What Is the Stock Symbol for Enovis Corp
The stock symbol (or 'ticker') for Enovis Corp is "ENOV."
What Stock Exchange Does Enovis Corp Trade On?
Enovis Corp is listed and trades on the NYSE stock exchange.
Is Enovis Corp a Good Stock to Buy?
Determining whether Enovis (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.22
29.31
52 wk Range
19.14
34.28
Earnings results expected in 3 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
28.2229.31
52 wk Range
19.1434.28
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ENOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
41.58
Upside
+42.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Form 4 Enovis Corp For: 1 July- Investing.com
- Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Colfax receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Analyst Ratings
12 Buy
1 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 41.58
(+42.65% Upside)
Enovis Corp Earnings Call Summary for Q1/2026
- Enovis Q1 2026 EPS of $0.89 beat forecast of $0.81 by 9.88%; revenue reached $589M vs. $573M expected, up 5% year-over-year.
- Stock surged 6.72% pre-market but declined 3.89% in subsequent sessions, reflecting mixed investor sentiment amid market volatility.
- Gross margin improved 40 basis points to 62%; adjusted EBITDA margin dipped to 17.6% due to increased R&D spending and tariff pressures.
- CEO McDonald highlighted ARVIS system launch and operational efficiency as growth drivers; company maintains optimistic outlook through 2027.
- Key risks include ongoing tariff impacts, supply chain disruptions, and macroeconomic volatility potentially affecting near-term profitability.
Last Updated: 13/05/2026, 14:42
Read Full TranscriptEarnings
Latest Release
07/05/2026
EPS / Forecast
0.89 / 0.81
Revenue / Forecast
589M / 573.02M
Compare ENOV to Peers and Sector
Metrics to compare | ENOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −4.6x | −0.4x | |
PEG Ratio | 0.04 | −0.85 | 0.00 | |
Price/Book | 1.1x | 3.6x | 2.6x | |
Price / LTM Sales | 0.7x | 2.1x | 3.0x | |
Upside (Analyst Target) | 37.2% | 25.2% | 56.0% | |
Fair Value Upside | Unlock | 24.7% | 9.1% | Unlock |
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Enovis (NYSE: ENOV) Share Price Today?
The Enovis stock price today is 29.15 USD.
What Stock Exchange Does Enovis (ENOV) Trade On?
Enovis is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Enovis?
The stock symbol (also called a 'ticker') for Enovis is "ENOV."
What Is the Current Enovis Market Capitalisation?
As of today, Enovis (NYSE: ENOV) market cap is 1.69B USD.
What Is Enovis's (ENOV) Earnings Per Share (TTM)?
The Enovis EPS is currently -19.85 (Trailing Twelve Months).
When Is the Next Enovis Earnings Date?
Enovis's next earnings report will be released on 06/08/2026.
Is ENOV a Buy or Sell From a Technical Analyst Perspective?
Based on today's Enovis moving averages and other technical indicators, the daily buy/sell signal for ENOV stock is Strong Buy.
How Many Times Has Enovis Stock Split?
Enovis has split 1 times. (See the ENOV stock split history page for full effective split date and price information.)
How Many Employees Does Enovis Have?
Enovis has 7802 employees, based on their latest Companies House report.
What is the current trading status of Enovis (NYSE: ENOV)?
As of 03/08/2026, Enovis (ENOV) is trading at a share price of 29.15 USD, with a previous close of 29.15 USD. The stock has fluctuated within a day range of 28.22 USD to 29.31 USD, while its 52-week range spans from 19.14 USD to 34.28 USD.
What Is Enovis (ENOV) Price Target According to Analysts?
The average 12-month price target for Enovis is 41.58 USD, with a high estimate of 55 USD and a low estimate of 29 USD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +42.65% Upside potential.
What Is the ENOV Premarket Price?
ENOV's last pre-market stock price is 28.79 USD. The pre-market share volume is 180.00, and the stock has decreased by -0.51, or -1.74%.
What Is the ENOV After Hours Price?
ENOV's last after hours stock price is 29.19 USD, the stock has decreased by 0.04, or 0.14%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.